UnitedHealth Group Incorporated (NYSE:UNH) Given New $213.00 Price Target at Citigroup Inc.
UnitedHealth Group Incorporated (NYSE:UNH) had its price objective raised by equities researchers at Citigroup Inc. from $195.00 to $213.00 in a research report issued to clients and investors on Wednesday. The brokerage presently has a “buy” rating on the healthcare conglomerate’s stock. Citigroup Inc.’s target price would indicate a potential upside of 14.00% from the stock’s current price.
UNH has been the subject of several other reports. Jefferies Group LLC restated a “buy” rating and issued a $192.00 price objective on shares of UnitedHealth Group in a research note on Friday, May 19th. Cantor Fitzgerald restated an “overweight” rating and issued a $205.00 price objective (up from $200.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Vetr lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $179.00 price objective for the company. in a research note on Monday, April 24th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $201.00 price objective for the company in a research note on Wednesday, June 7th. Finally, Evercore ISI restated an “outperform” rating and issued a $185.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 19th. One research analyst has rated the stock with a hold rating and twenty-six have issued a buy rating to the company. UnitedHealth Group presently has an average rating of “Buy” and an average target price of $192.22.
Shares of UnitedHealth Group (NYSE:UNH) traded up 0.90% during trading on Wednesday, hitting $188.53. The stock had a trading volume of 963,928 shares. The firm has a market capitalization of $181.68 billion, a P/E ratio of 24.13 and a beta of 0.64. UnitedHealth Group has a 1-year low of $132.39 and a 1-year high of $189.36. The stock’s 50-day moving average price is $183.60 and its 200 day moving average price is $171.00. UnitedHealth Group also was the recipient of some unusual options trading on Monday. Stock traders acquired 9,979 put options on the stock. This is an increase of 595% compared to the average volume of 1,435 put options.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a return on equity of 21.42% and a net margin of 4.13%. UnitedHealth Group’s revenue was up 7.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.96 EPS. On average, analysts anticipate that UnitedHealth Group will post $9.83 earnings per share for the current year.
WARNING: This news story was first reported by Watch List News and is the property of of Watch List News. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://www.watchlistnews.com/unitedhealth-group-incorporated-nyseunh-given-new-213-00-price-target-at-citigroup-inc/1452511.html.
In related news, Director Gail R. Wilensky sold 5,540 shares of the stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the transaction, the director now owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the transaction, the director now directly owns 75,735 shares of the company’s stock, valued at approximately $13,832,240.40. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,540 shares of company stock valued at $2,755,770. Company insiders own 0.89% of the company’s stock.
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. State Street Corp increased its position in shares of UnitedHealth Group by 2.5% in the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after buying an additional 1,122,534 shares during the last quarter. Dodge & Cox acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $1,658,560,000. Norges Bank acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $1,530,177,000. Legal & General Group Plc increased its position in shares of UnitedHealth Group by 5.4% in the first quarter. Legal & General Group Plc now owns 4,954,692 shares of the healthcare conglomerate’s stock worth $812,630,000 after buying an additional 254,545 shares during the last quarter. Finally, Harris Associates L P increased its position in shares of UnitedHealth Group by 0.3% in the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock worth $762,041,000 after buying an additional 14,489 shares during the last quarter. 86.21% of the stock is owned by hedge funds and other institutional investors.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.